Close



Aug 3, 2023 04:05PM
May 2, 2023 04:05PM
Feb 23, 2023 04:05PM
May 5, 2022 04:02PM
Feb 28, 2022 04:02PM
Jan 10, 2022 08:00AM
Nov 4, 2021 04:02PM Dynavax Reports Third Quarter 2021 Financial Results
Aug 23, 2021 08:04AM
Aug 23, 2021 08:00AM
Aug 6, 2021 07:59AM
Aug 4, 2021 04:02PM
May 22, 2020 09:29AM
Jun 28, 2018 06:30AM
May 8, 2018 04:05PM Dynavax Reports First Quarter 2018 Financial Results
Apr 23, 2018 06:39AM
Apr 23, 2018 06:30AM
Mar 8, 2018 06:30AM
Feb 21, 2018 09:39AM
Feb 21, 2018 09:36AM
Feb 20, 2018 06:42AM
Feb 20, 2018 06:30AM Dynavax Secures $175 Million in Non-Dilutive Debt Financing
Jan 8, 2018 06:09AM
Jan 8, 2018 06:00AM
Nov 9, 2017 04:47PM
Nov 9, 2017 04:45PM
Nov 3, 2017 06:30AM
Aug 4, 2017 09:21AM
Aug 3, 2017 06:17PM After-Hours Stock Movers 08/03: (YELP) (WTW) (ANET) Higher; (AAOI) (PI) (SYNA) Lower (more...)
Aug 3, 2017 04:05PM
Aug 3, 2017 04:00PM
Aug 2, 2017 06:00AM
Jul 31, 2017 09:32AM
Jul 28, 2017 04:36PM
Jul 28, 2017 04:35PM
Jul 28, 2017 07:13AM Dynavax (DVAX) Halted Ahead of FDA Advisory Committee Meeting
May 8, 2017 06:00AM
Apr 3, 2017 09:29AM
Apr 3, 2017 06:05AM
Apr 3, 2017 06:00AM
Mar 13, 2017 06:00AM
Feb 28, 2017 04:02PM
Feb 28, 2017 04:01PM Dynavax Announces FDA Acceptance for Review of Its Complete Response to November 2016 CRL and PDUFA Action Date for HEPLISAV-B(TM)
Jan 5, 2017 12:36PM
Jan 5, 2017 12:35PM
Nov 14, 2016 06:31AM
Nov 14, 2016 06:30AM
Nov 7, 2016 06:00AM
Oct 26, 2016 09:05AM
Oct 26, 2016 09:00AM Dynavax Presents Data Showing That HEPLISAV-B Provides Significantly Higher Seroprotection Rates Against Hepatitis B Infection in Populations Known to Have a Reduced Immune Response to Currently Licen
Oct 3, 2016 07:49AM

12,639 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All